insights_auto
Why is INO down 2.65%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
$1.47
arrow_downward
-2.65%(-0.040) 1D
Nov 10, 1:01:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
$1.48
High
$1.50
Low
$1.42
Mkt. cap
247.48M
Avg. vol.
18.40M
Volume
7.18M
52-wk high
$2.72
52-wk low
$0.57
EPS
-$1.17
Beta
1.71
Shares outstanding
103.40M
No. of employees
112
Open
$1.48
High
$1.50
Low
$1.42
Mkt. cap
247.48M
Avg. vol.
18.40M
Volume
7.18M
52-wk high
$2.72
52-wk low
$0.57
EPS
-$1.17
Beta
1.71
Shares outstanding
103.40M
No. of employees
112
News stories
From web sources and news partners
Investing.com UK
·
1 day ago
Form 8K Inovio Pharmaceuticals Inc For: 9 November By Investing.com
TradingView
·
1 day ago
INO Q3'26 Earnings: EPS estimate is (0.20) USD
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc
CEOJacqueline Shea
Employees112
Founded1999
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteinovio.com